Claro Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Claro Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$392K	Sell	782 -6	-0.8%	-$2.88K	0.04%	331
2026 Q1	$387K	Buy	788 +17	+2%	+$9.23K	0.05%	303
2025 Q4	$447K	Buy	771 +40	+5%	+$22.6K	0.06%	247
2025 Q3	$355K	Sell	731 -7	-0.9%	-$3.26K	0.05%	285
2025 Q2	$299K	Sell	738 -284	-28%	-$119K	0.05%	293
2025 Q1	$508K	Buy	1,022 +122	+14%	+$66.1K	0.07%	260
2024 Q4	$468K	Sell	900 -399	-31%	-$219K	0.06%	256
2024 Q3	$804K	Buy	1,299 +558	+75%	+$330K	0.1%	191
2024 Q2	$410K	Buy	741 +148	+25%	+$84.8K	0.06%	261
2024 Q1	$345K	Buy	+593	New	+$333K	0.06%	296
2019 Q1	–	Sell	-146	Closed	-$36K	–	855
2018 Q4	$36K	Buy	+146	New	+$34.3K	0.03%	408

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Claro Advisors's TMO Position: Q2 2026 in Review

Claro Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.76% in Q2 2026, selling an estimated $2.88K and leaving 782 shares worth $392K. The position accounts for 0.04% of the portfolio, ranked #331.

Claro Advisors first reported a position in TMO in Q4 2018 and has held it in 11 quarters since. The position peaked at $804K in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Claro Advisors held 782 shares of Thermo Fisher Scientific worth $392K as of Q2 2026.
Claro Advisors sold 6 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.88K.
Thermo Fisher Scientific made up 0.04% of Claro Advisors's portfolio in Q2 2026, its #331 holding.
Claro Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 11 quarters since.
Claro Advisors's Thermo Fisher Scientific position peaked at $804K in Q3 2024.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Claro Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.